Single Ascending Dose and Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-1816 in Healthy Subjects

Summary

This is a randomized, double-blind, placebo-controlled study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of SHR-1816 after single and multiple injection with different dose regimens in healthy subjects.

Timeline

Start

2022-05-18

Primary completion

2022-09-05

Completion

2022-09-05

Outcome

Outcome not reported

Stopped (Business): “Sponsor internal strategy change.”

Drugs

Indications